IREHF (Integrated Research) Other Long-Term Liabilities: $0.22 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IREHF Integrated Research Ltd IREHF
48 GF Score
Price $0.20
GF Value $0.20
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Integrated Research Other Long-Term Liabilities?

Integrated Research IREHF 48 Other Long-Term Liabilities is $0.22 Mil as of Dec. 2025. GuruFocus rates IREHF with a GF Score™ of 48/100 and a GF Value™ of $0.20 (Fairly Valued). The stock has 4 warning signs investors should review.

Integrated Research's other long-term liabilities for the quarter that ended in Dec. 2025 was $0.22 Mil.

Integrated Research's quarterly other long-term liabilities declined from Dec. 2024 ($0.21 Mil) to Jun. 2025 ($0.04 Mil) but then increased from Jun. 2025 ($0.04 Mil) to Dec. 2025 ($0.22 Mil).

Integrated Research's annual other long-term liabilities declined from Jun. 2023 ($0.26 Mil) to Jun. 2024 ($0.02 Mil) but then increased from Jun. 2024 ($0.02 Mil) to Jun. 2025 ($0.04 Mil).

Integrated Research Other Long-Term Liabilities Related Terms

Integrated Research Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Integrated Research's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrated Research Other Long-Term Liabilities Chart

Integrated Research Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.33 0.26 0.02 0.04

Integrated Research Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.02 0.21 0.04 0.22
IREHF
48GF Score
Integrated Research Ltd IREHF
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integrated Research Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $0.22 Mil mean?
Integrated Research (IREHF) has a Other Long-Term Liabilities of $0.22 Mil as of Dec. 2025. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Integrated Research and its competitors.
Is Integrated Research's Other Long-Term Liabilities too high?
Integrated Research's current Other Long-Term Liabilities is $0.22 Mil. Overall, Integrated Research has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Integrated Research's Other Long-Term Liabilities compare to QH and SHOP?
Integrated Research's Other Long-Term Liabilities of $0.22 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Software company?
A good Other Long-Term Liabilities depends on the Software industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Integrated Research and its competitors. Integrated Research's current Other Long-Term Liabilities is $0.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrated Research stock overvalued right now?
Based on GuruFocus' analysis, Integrated Research (IREHF) is currently considered Fairly Valued. The stock's GF Value™ is $0.20, compared to a current price of $0.20 — trading right at its estimated fair value. The current Other Long-Term Liabilities is $0.22 Mil. Integrated Research's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Integrated Research (IREHF), the current Other Long-Term Liabilities is $0.22 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integrated Research (IREHF) Overvalued in 2026?

Based on GuruFocus' analysis, Integrated Research stock appears to be undervalued. The current stock price of $0.20 is trading 0% below its estimated GF Value™ of $0.20. GuruFocus considers Integrated Research to be Fairly Valued.

Key valuation signals for IREHF:

  • Other Long-Term Liabilities: $0.22 Mil
  • GF Value™: $0.20 vs. price of $0.20 (0% below fair value)
  • GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the IREHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integrated Research Business Description

Other Exchanges IRI:Australia
Address 420 George Street, Suite 9.03, Level 9, Sydney, NSW, AUS, 2000
Integrated Research Ltd is engaged in the design, development, implementation, and sale of systems and applications management computer software for business-critical computing, Unified Communication networks, and Payment networks. Its Prognosis platform is an integrated suite of monitoring and management software, designed to give its clients, an operational insight into and optimize the operation of their HP NonStop, distributed system servers, Unified Communications (UC), Payment environments, and the business applications that run on these platforms. The company's geographic segments include Asia Pacific, Americas, and Europe. It generates revenue from licence fees, maintenance fees, subscription fees, testing solution services, and professional services.
48GF Score

Get the complete analysis for IREHF

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.20
Price
$0.20
GF Value